We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (236)
- COVID-19 (55)
- Compliance and enforcement (48)
- Vaping hub (33)
- Import and export (21)
- Medicinal cannabis hub (19)
- Safety monitoring and information (13)
- Scheduling (national classification system) (13)
- Manufacturing (11)
- Weight loss products (8)
- Legislation (7)
- Labelling and packaging (4)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Committees and advisory bodies (1)
- Fees and payments (1)
- Sunscreens (1)
Search
530 result(s) found, displaying 501 to 525
-
Media releasesThe TGA begins piloting electronic submissions for registered medicines using the eCTD format, supported by updated software and a revised Module 1 aligned with European standards.
-
-
Media releasesPharmacy software vendor links to TGA adverse event reporting web service
-
Media releases
-
Media releases
-
Media releasesConsultation on low value turnover exemption (LVT) scheme
-
-
Media releases
-
Media releases
-
Media releasesThe TGA reviewed studies on tartrazine, a yellow colouring used in medicines, and found it safe when properly labelled, with no strong evidence of harm like allergies or behavioural issues.
-
Media releases
-
Media releases
-
Media releasesPilot web service for transmission of adverse event reports from medical software to the Therapeutic Goods Administration
-
Compliance undertakings
-
Media releases
-
-
-
Media releases
-
Media releases
-
Media releases
-
-
-
Media releases
-
-
Media releases